These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19631914)

  • 21. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
    Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.
    Satow R; Shitashige M; Kanai Y; Takeshita F; Ojima H; Jigami T; Honda K; Kosuge T; Ochiya T; Hirohashi S; Yamada T
    Clin Cancer Res; 2010 May; 16(9):2518-28. PubMed ID: 20388846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2].
    Tang L; Sun H; Zhang L; Guo H; Zhang L; Liu Q
    Ai Zheng; 2006 Jun; 25(6):671-6. PubMed ID: 16764759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in basic fibroblast growth factor RNA and protein levels in human primary melanocytes and metastatic melanoma cells.
    Yamanishi DT; Graham MJ; Florkiewicz RZ; Buckmeier JA; Meyskens FL
    Cancer Res; 1992 Sep; 52(18):5024-9. PubMed ID: 1516057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of basic fibroblast growth factor on the proliferation of non-small cell lung cancer cell lines.
    Kuhn H; Köpff C; Konrad J; Riedel A; Gessner C; Wirtz H
    Lung Cancer; 2004 May; 44(2):167-74. PubMed ID: 15084381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of fibroblast growth factor 2 expression by antisense RNA induced a loss of the transformed phenotype in a human hepatoma cell line.
    Maret A; Galy B; Arnaud E; Bayard F; Prats H
    Cancer Res; 1995 Nov; 55(21):5075-9. PubMed ID: 7585554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. beta-catenin siRNA regulation of apoptosis- and angiogenesis-related gene expression in hepatocellular carcinoma cells: potential uses for gene therapy.
    Wang XH; Sun X; Meng XW; Lv ZW; Du YJ; Zhu Y; Chen J; Kong DX; Jin SZ
    Oncol Rep; 2010 Oct; 24(4):1093-9. PubMed ID: 20811694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma.
    El-Assal ON; Yamanoi A; Ono T; Kohno H; Nagasue N
    Clin Cancer Res; 2001 May; 7(5):1299-305. PubMed ID: 11350898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
    Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basic fibroblast growth factor upregulates survivin expression in hepatocellular carcinoma cells via a protein kinase B-dependent pathway.
    Sun B; Xu H; Zhang G; Zhu Y; Sun H; Hou G
    Oncol Rep; 2013 Jul; 30(1):385-90. PubMed ID: 23677479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: an export-dependent mechanism of action.
    Coltrini D; Gualandris A; Nelli EE; Parolini S; Molinari-Tosatti MP; Quarto N; Ziche M; Giavazzi R; Presta M
    Cancer Res; 1995 Oct; 55(20):4729-38. PubMed ID: 7553656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inhibitory effect of cyclin D1 antisense cDNA on human hepatocarcinoma cell line HepG2].
    Xiao ZY; Chen XP; Huang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):768-71. PubMed ID: 16248951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells.
    Tavian D; Salvi A; De Petro G; Barlati S
    Cancer Gene Ther; 2003 Feb; 10(2):112-20. PubMed ID: 12536199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of small interfering RNA targeting basic fibroblast growth factor on proliferation and apoptosis of glioma cell line U251].
    Wang SJ; Wang JH; Zhang YW; Xu XN; Liu HS
    Ai Zheng; 2008 Sep; 27(9):905-9. PubMed ID: 18799025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
    Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
    Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of bFGF on invasion of ovarian cancer cells through the regulation of Ets-1 and urokinase-type plasminogen activator.
    Li T; Jiang S
    Pharm Biol; 2010 Feb; 48(2):161-5. PubMed ID: 20645833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells.
    Kim Y; Yoon JW; Xiao X; Dean NM; Monia BP; Marcusson EG
    Cancer Res; 2007 Apr; 67(8):3583-93. PubMed ID: 17440069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting alpha-fetoprotein represses the proliferation of hepatoma cells via regulation of the cell cycle.
    Tang H; Tang XY; Liu M; Li X
    Clin Chim Acta; 2008 Aug; 394(1-2):81-8. PubMed ID: 18485897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
    Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased expressions of hepsin in human hepatocellular carcinomas.
    Chen CH; Su KY; Tao MH; Lin SW; Su YH; Tsai YC; Cheng KC; Jeng YM; Sheu JC
    Liver Int; 2006 Sep; 26(7):774-80. PubMed ID: 16911458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.